Greenwood, J <br/><br/>
Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysis.  [electronic resource] 

 -  Therapeutic immunology  Oct 1994 
 - 247-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0967-0149 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alemtuzumab<br/>Antibodies, Monoclonal--chemistry<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm<br/>Antigens, CD--immunology<br/>Antigens, Neoplasm<br/>Base Sequence<br/>CD52 Antigen<br/>Cells, Cultured<br/>Complement Activation<br/>Cytotoxicity, Immunologic<br/>DNA Primers--chemistry<br/>Dose-Response Relationship, Immunologic<br/>Glycoproteins<br/>Humans<br/>Immunoglobulin G--chemistry<br/>Molecular Sequence Data<br/>Repetitive Sequences, Nucleic Acid<br/>Structure-Activity Relationship<br/>T-Lymphocytes--immunology